Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Net Margin (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Net Margin for 12 consecutive years, with 72319.9% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 45622634.0% year-over-year to 72319.9%, compared with a TTM value of 1326.37% through Dec 2025, down 235839.0%, and an annual FY2025 reading of 26360.05%, down 2739206.0% over the prior year.
  • Net Margin was 72319.9% for Q4 2025 at Abvc Biopharma, up from 161.76% in the prior quarter.
  • Across five years, Net Margin topped out at 528546.24% in Q4 2024 and bottomed at 242959.67% in Q1 2024.
  • Average Net Margin over 5 years is 27910.65%, with a median of 428.04% recorded in 2021.
  • The sharpest move saw Net Margin soared 28508641bps in 2023, then crashed -45622634bps in 2025.
  • Year by year, Net Margin stood at 20988.69% in 2021, then plummeted by -92bps to 1746.16% in 2022, then surged by 16327bps to 286832.56% in 2023, then surged by 84bps to 528546.24% in 2024, then plummeted by -86bps to 72319.9% in 2025.
  • Business Quant data shows Net Margin for ABVC at 72319.9% in Q4 2025, 161.76% in Q3 2025, and 1784.37% in Q2 2025.